期刊文献+

中国ST段抬高的急性心肌梗死临床特征及治疗现状 被引量:85

Clinical characteristics and management of patients with ST segment elevation myocardial infarction in China: survey of 7510 cases
原文传递
导出
摘要 目的分析中国ST段抬高心肌梗死(STEMI)的基线特征及治疗现状。方法作为国际多中心试验CREATE研究的一部分,2001年7月至2004年7月入选症状出现12小时内的STEMI病人,分析基线特征及治疗现状。结果中国274中心入选7510例病人,STEMI病人中0.7%为新出现的左束支传导阻滞。平均年龄62.7岁。11.5%接受PCI治疗,溶栓治疗52.5%,冠状动旁路移植术0.1%,总体接受再灌注治疗(包括溶栓及直接PCI)为62.4%。其他药物治疗情况与以往的登记研究相似。7天的死亡、卒中、再梗死联合终点为10.3%。30天总死亡率为11.1%。结论与全组急性冠脉事件登记研究相比较;中国STEMI病人的发病年龄与之相类似,伴发高血压者较多,有糖尿病史者稍少,接受再灌注率相似。但在再灌注治疗及药物治疗上还存在进一步改善的空间。 Objective To analyze the clinical characteristics and management of the patients with ST segment elevation myocardial infarction (STEMI) in China. Methods As part of the international multicentre CREATE Study, the clinical data of 7510 patients with STEMI presenting their symptoms within 12 hours of onset who were hospitalized in 274 centers throughout China from July 2001 through July 2004,aged 62. 7, were collected to be analyzed. Results 99. 3% of these patients had STEMI, and 0. 7% had new left bundle-branch block. 11.5% of them underwent percutaneous coronary intervention( PCI), 52. 5% underwent thrombolytic therapy , and 0. 1% coronary artery bypass grafting. All types of reperfusion therapy were carried out to 62.4% of the patients during the hospitalization. The medication therapy used was similar to those in the previous Registry report. The composite of all-cause mortality, re-infarction, and stroke within the first 7 days was 10. 3% and the all-cause mortality within 30 days was 11.1%. Conclusion The clinical characteristics and management of the STEMI patients in China have been described. The age of onset of STEMI is 62 years on average. The most common complication is hypertension, and diabetes mellitus is relatively rare. rt-PA was used rarely mainly because of the expensive price. A large proportion of patients in China receive reperfusion, which is worth recommendation. Active intervention should be carried out in the early stage after infarction.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第31期2176-2182,共7页 National Medical Journal of China
关键词 心肌梗塞 临床方案 基线特征 治疗 溶栓治疗 PCI治疗 Myocardial, infarction Clinical protocols Baseline characteristics
  • 相关文献

参考文献3

二级参考文献34

  • 1谭慧琼,朱俊,梁岩,章晏,刘力生,代表OASIS登记试验中国地区协作组.非ST段抬高的急性冠状动脉综合征二年随访[J].中华医学杂志,2005,85(3):184-188. 被引量:12
  • 2Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals:a randomized placebo-controlled trial. Lancet, 2002, 360: 7-22.
  • 3Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstabe angina or myocardial infarction without initial ST elevation. Lancet, 1998, 352: 507-514.
  • 4Collinson J, Flather MD, Fox KA, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and mycardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J, 2000, 21: 1450-1457.
  • 5Granger CB. Strategies of patient care in acute coronary syndromes: rationals for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol, 2000, 86 Suppl: 4M-9M.
  • 6Stone PH, Thompson B, Anderson HV, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III Registry. JAMA, 1996,275:1104-1112.
  • 7Spencer FA, Santopinto JJ, Gore JM, et a1. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronarv Events [GRACE]).Am J Cardiol, 2002, 90: 1056-1061.
  • 8Patrono C,Bachmann F,Baigent C,et al. Expert consensus document on the use of antiplatelet agents: the task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J, 2004, 25: 166-181.
  • 9Braunwaid E, Antman EM, Beasley JW, et al. ACC/AHA Guideline update for the management of patients with unstabe angina and non-ST-segment elevation myocardial infarction-2002: summary article. Circulation, 2002, 106: 1893-1990.
  • 10Hjalmarson F, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalization, and well-being in patients with heart failure. The metoprolol CR / XL randomized international trial in congestive heart failure (MERIT-HF). JAMA, 2000, 238: 1295-1302.

共引文献93

同被引文献640

引证文献85

二级引证文献1271

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部